glp-1 telehealth crackdown news today FDA warnings against compounded GLP-1s raise the stakes for telehealths selling branded drugs Telehealth booms on surging GLP-1
Description
Andersen A, Lund A, Knop FK, Vilsbll T (2018) Glucagon-like peptide 1 in health and disease
Always obtain GLP-1 medications from a licensed pharmacy with a valid prescription
In September 2024, SK pharmteco invested US$260 million to establish a five-story, 135,800-square-foot facility in Sejong, South Korea, to enhance the its peptide and small-molecule API manufacturing capabilities
A simple once-daily tablet with no injections required
The blog also explains its role in clinical trials
